Compounds of the Formula: ##STR00001## where X.sup.1, Ar.sup.1, R.sup.1, and R.sup.2 are as defined herein, and compositions comprising the same. Also provided are methods for using compounds of Formula I in treating p38 mediated disorders in a patient.

 
Web www.patentalert.com

< Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors

< Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation

> Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same

> Compounds having CRTH2 antagonist activity
~ 00620